Healthy Elderly Clinical Trial
Official title:
A Double-blind, Randomized, Placebo-controlled, Multiple Ascending Dose (MAD) Study in Healthy Elderly Volunteers and Alzheimer's Disease (AD) Patients to Investigate the Safety and Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) Effects of Multiple Intravenous Infusions of NX210c
This study will investigate the safety and tolerability of multiple intravenous infusions of NX210c with two ascending doses as well as NX210c pharmacokinetics (PK), and pharmacodynamics (PD) effects, firstly in healthy elderly subjects, and the recommended dose to be used for Alzheimer's disease patients, in a second step.
The prevalence of neurocognitive disorders (NCD), including neurodegenerative diseases (NDDs) such as Alzheimer's disease (AD) is increasing. NDDs are most common and prevalent in elderly people worldwide and cause progressive neuronal dysfunction, toxicities, and death. These diseases lead to an irreversible weakening of all brain functions, including cognitive impairment. There is not one single cause of cognitive impairment but rather several factors that can contribute to trigger or accelerate cognitive decline. Preclinical in vitro and in vivo data have shown that NX210c exhibits important properties, which may be suitable for the treatment of neurological disorders in humans. (i.e., neuroprotection, neuro-regeneration, synaptic transmission, positive effects on cognition, anti-neuroinflammatory action). The First In Human Single Ascending Dose study has been completed. In that study, NX210 was administered and well tolerated. The current project is a multiple ascending dose (MAD) study and designed to investigate the safety, tolerability, PK and pharmacodynamics (PD) effects of multiple intravenous infusions of NX210c in two dose levels in healthy elderly subjects. An additional cohort enrolling patient with Alzheimer disease (AD) to further evaluate NX210c is planned for this study but design is still in development. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04795284 -
Biomechanical Parameters of Gait in Patients With Symptomatic Lumbar Spinal Stenosis and Healthy Elderly.
|
||
| Completed |
NCT02235168 -
Effect of Rollator on Walking Distance in Elderly Patients
|
N/A | |
| Terminated |
NCT01421446 -
Study to Validate a Computerized Neuropsychological Test Battery
|
N/A | |
| Completed |
NCT03536871 -
Exercise and Nutritional Supplementation
|
N/A | |
| Recruiting |
NCT03691129 -
Yoga Efficacy and Bioactive Materials in the Blood of Korean Elderly
|
N/A | |
| Completed |
NCT02376270 -
Pectin, Aging and Intestinal Barrier Function
|
Phase 4 | |
| Terminated |
NCT02170012 -
A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649
|
Phase 1 | |
| Completed |
NCT04028648 -
Generation of Prediction Equations for BIA of the Elderly
|
||
| Completed |
NCT02036645 -
SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.
|
Phase 1 | |
| Completed |
NCT02063646 -
Effect of a Polyphenol-rich Food Supplement on Cognitive Function in Healthy Aging Adults
|
N/A | |
| Completed |
NCT04350177 -
A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients
|
Phase 1 | |
| Completed |
NCT00931814 -
Effects of Exercise on Depression Symptoms, Physical Function, and Quality of Life in Community-Dwelling Elderly
|
N/A | |
| Withdrawn |
NCT02765425 -
Training the Brain With a Robotic Device for Balance Recovery
|
N/A | |
| Completed |
NCT02125305 -
Clinical Study to Investigate the Pharmacokinetics and Pharmacodynamics of Metformin in the Elderly
|
Phase 1 | |
| Completed |
NCT01188382 -
Reference Values of Cerebrospinal Fluid Outflow Resistance and Intracranial Pressure in Healthy Elderly
|
N/A | |
| Suspended |
NCT04086589 -
Restoring Molecular Circadian Rhythm
|